NCINVEST 2004 Presenter Profiles.
CHAPEL HILL, N.C.--(BUSINESS WIRE)--Feb. 25, 2004
NCINVEST 2004 takes place on February 26, 2004 at The Friday Center in Chapel Hill, North Carolina. For in-depth information about the event visit http://www.ncinvest.org/about.html.
Below are profiles from NCINVEST 2004 presenters; breaking news releases are available at http://www.tradeshownews.com, Business Wire's trade show and conference news resource.
Company: Charles & Colvard Ltd. Ticker Symbol: CTHR Investor Relations Contact: Jim Braun Phone: 919 468 0399 E-mail: email@example.com Company URL: moissanite.com Moissanite is near colorless jewel, that has more fire, brilliance and luster than a fine diamond, but retails for only a fraction of the cost. Moissanite jewels are produced from silicon carbide (SiC) crystals. Moissanite jewelry is sold in fine jewelry stores, on domestic and international shopping networks, in catalogs and online. Charles & Colvard Ltd. is the sole source of moissanite, a created jewel used in fine jewelry. Charles & Colvard creates a range of sizes and shapes of sparkling moissanite jewels, which it sells to jewelry manufacturers and exclusive distributors in the U.S. and abroad. Charles and Colvard has the patent for the use of silicon carbide (SiC) as a jewel. Company: Closure Medical Corporation Ticker Symbol: CLSR Media Contact: Benny Ward Investor Relations Contact: Benny Ward Phone: 919.876.7800 E-mail: firstname.lastname@example.org Company URL: www.closuremed.com Press Area URL: www.closuremed.com/index.cfm/fuseaction/page/filename/newsreleases .html Closure's leading product, DERMABOND adhesive, is sold to healthcare professionals and can be used instead of sutures or staples. Other products developed by the Company include BAND-AID(R) Brand Liquid Bandage and Orabase(R) SOOTHE-N-SEAL(R) canker sore relief. In addition, the company has two veterinary products in its NEXABAND(R) product line. Closure Medical Corporation develops and manufactures innovative biomaterial-based medical devices for wound care and wound closure for healthcare practitioners, patients and consumers based on its proprietary medical grade cyanoacrylate technology. The Company's research efforts have also included the development of internal adhesive products. Company: Cree, Inc. Ticker Symbol: CREE Media Contact: Fran Barsky Investor Relations Contact: Fran Barsky Phone: 919-313-5397 E-mail: email@example.com Company URL: www.cree.com Cree, Inc. develops and manufactures semiconductor materials and electronic devices made from silicon carbide (SiC) and gallium nitride (GaN). The Company uses its proprietary technology to produce compound semiconductors such as blue and green light emitting diodes (LEDs) for use in automotive, mobile appliances and liquid crystal displays (LCD); full color indoor and outdoor displays; indicator lamps, and other lighting applications. The Company also manufacturers and sells SiC wafers which are used for research directed toward optoelectronic, microwave and power device applications. Company: Embrex, Inc. Ticker Symbol: EMBX Media Contact: Ellen Moore Investor Relations Contact: Ellen Moore Phone: (919) 314-2561 E-mail: firstname.lastname@example.org Company URL: www.embrex.com Embrex products: Inovoject(R) egg injection system vaccinates poultry while it is still in the egg. Egg Remover(R) identifies infertile and early dead eggs and removes them from tray before vaccination. Bursaplex(R) IBD vaccine is the only single-dose effective IBD vaccine that safely protects birds in the presence of maternal antibody. Embrex, Inc., The In Ovo Company(SM )(Nasdaq: EMBX), is an international agricultural biotechnology company focused on developing and commercializing patented biological, pharmaceutical and mechanical and that improve bird health, reduce bird production costs and provide economic benefits to the global poultry industry. Company: EnPro Industries, Inc. Ticker Symbol: NPO Media Contact: Don Washington Investor Relations Contact: Don Washington Phone: 704 731-1527 E-mail: email@example.com Company URL: www.enproindustries.com Press Area URL: http://www.corporate-ir.net/ireye/ir_site.zhtml?ticker=NPO&script=400 EnPro Industries, Inc., with 2003 sales of $730 million, is a leader in sealing products, metal polymer bearings, compressor systems, diesel and dual-fuel engines and other engineered products for use in critical applications by industries worldwide. The company employs over 4,400 people and is headquartered in Charlotte, NC. Company: Piedmont Natural Gas Ticker Symbol: PNY Media Contact: Steve Conner Investor Relations Contact: Headen Thomas Phone: 704-731-4438 E-mail: firstname.lastname@example.org Company URL: www.piedmontng.com Press Area URL: http://ir.thomsonfn.com/InvestorRelations/PubNews.aspx?partner=Mzg0T1R rNU5BPT1QJFkEQUALSTO&product=MzgwU1ZJPVAkWQEQUALSTOEQUALSTO The company distributes natural gas. Based in Charlotte, Piedmont Natural Gas (NYSE:PNY) is an energy services company primarily engaged in the distribution of natural gas to 940,000 residential, commercial and industrial utility customers in North Carolina, South Carolina and Tennessee, including 60,000 customers served by municipalities who are wholesale customers. Our subsidiaries are invested in joint venture, energy-related businesses, including unregulated retail natural gas marketing, interstate natural gas storage, intrastate transportation and regulated natural gas distribution. PNY is one of the fastest-growing natural gas distributors in the nation. Dividends have increased every year since 1978 and the average annual compound return on PNY shares has been 16% over the past 20 years. Company: SpectraSite, Inc. Ticker Symbol: SSI Media Contact: Noreen Allen 919-465-6678 Investor Relations Contact: Investor Relations Department 919-466-5492 E-mail: email@example.com Company URL: www.spectrasite.com Press Area URL: www.spectrasite.com SpectraSite, Inc., based in Cary, North Carolina, is one of the largest wireless tower operators in the United States. As of December 31, 2003, SpectraSite owned or operated approximately 10,000 revenue producing sites, including 7,577 towers and in-building sites primarily in the top 100 markets in the United States. SpectraSite's customers are leading wireless communications providers, including AT&T Wireless, Cingular, Nextel, Sprint PCS, T-Mobile and Verizon Wireless. Company: Trimeris.com Ticker Symbol: TRMS Media Contact: Robin Fastenau Investor Relations Contact: Robin Fastenau Phone: 919.419.6050 E-mail: firstname.lastname@example.org Company URL: www.trimeris.com Press Area URL: http://www.trimeris.com/news/ Product description: FUZEON(R) (enfuvirtide), approved in the U.S., Canada and European Union, is the first in a new class of anti-HIV drugs called fusion inhibitors. Unlike other HIV drugs that work after the virus has infected the human immune cell, Fuzeon works outside the cell and blocks HIV from entering. Company description: Trimeris, Inc. is a biopharmaceutical company based in Durham, North Carolina. The Company's mission is to discover, develop and commercialize novel therapeutics that meet important medical needs, and we are currently engaged in the discovery and development of new drugs for the treatment of viral disease. Company: TriPath Imaging, Inc., Ticker Symbol: TPTH Media Contact: Jenny Kobin Investor Relations Contact: Jenny Kobin Phone: 919-206-7195 E-mail: email@example.com Company URL: www.tripathimaging.com TriPath Imaging, Inc., headquartered in Burlington, North Carolina, develops, manufactures, markets and sells innovative solutions to improve the clinical management of cancer, including detection, diagnosis, staging and treatment. TriPath Oncology, a wholly owned subsidiary of TriPath Imaging, develops molecular diagnostic and pharmacogenomic products and services for malignant melanoma and cancers of the cervix, breast, ovary and prostate. For more information on the Company, please go to www.tripathimaging.com or call (866)TRI-PATH.
|Printer friendly Cite/link Email Feedback|
|Date:||Feb 25, 2004|
|Previous Article:||Computer Resolutions Inc. to Distribute New Sun Servers.|
|Next Article:||IVAX Enters Marketing and Distribution Agreement with Mayne Pharmaceuticals for Injectable Paclitaxel in Europe.|